首页 > 专栏 > The Lancet Respiratory Medicine The Lancet Respiratory Medicine 共 21 条资讯 [Spotlight] Fair Doses: An Insider's Story of the Pandemic and the Global Fight for Vaccine Equity [Spotlight] Raphael's last fever [News] US EPA to roll back restrictions on upwind pollution [Comment] When evidence is not enough: making videolaryngoscopy the default for tracheal intubation [News] UK trials AI and robotics to detect lung cancer earlier [Comment] Ten unanswered questions about dipeptidyl peptidase-1 inhibition in bronchiectasis [Articles] Epidemiology, ventilation, and outcomes of acute respiratory failure in immunocompromised patients from 103 intensive care units in 26 countries: a retrospective observational study [Comment] Acute respiratory failure in immunocompromised adults: the case for personalised care strategies [Comment] Surfactant therapy in severe infant bronchiolitis: evidence from the BESS trial [Articles] Endotracheal surfactant for infants with life-threatening bronchiolitis (BESS): a randomised, blinded, sham-controlled, phase 2 trial [Comment] Rethinking the role of procalcitonin in suspected sepsis [Articles] Procalcitonin testing combined with NEWS2 evaluation compared with usual care based on NEWS2 for identification of sepsis and antibiotic initiation in the emergency department in England and Wales (PRONTO): a multicentre, randomised, controlled [Articles] Polymyxin B haemoadsorption in endotoxic septic shock (Tigris): a multicentre, open-label, Bayesian, randomised, controlled, phase 3 trial [Comment] Implementing endotoxin adsorption for septic shock into clinical practice [Position Paper] Consensus definition of stage III non-small-cell lung cancer technical resectability to standardise inclusion criteria for clinical trials: a multisocietal EORTC-Lung Cancer Group collaboration [Corrections] Correction to Lancet Respir Med 2026; 14: 417–31 [Comment] #Post-tuberculosis lung disease: no ICD code, no problem? [Comment] Rilzabrutinib and the evolving landscape of oral therapies for uncontrolled asthma [Articles] Rilzabrutinib for patients with moderate-to-severe asthma with uncontrolled symptoms: a double-blind, placebo-controlled, phase 2 study [Editorial] Campaigning to improve sepsis recognition and outcomes 12下一页 » 相关分类 The Lancet Respiratory Medicine The Lancet #!/slash/note #UNTAG (B)(F)uzzing on my world (Hi)story (IN)SECURE Magazine Notification (gdb) break *0x972 - 带鱼博客 BeltfishBlog - ./kwaa.dev .NET Blog .Trash /home/rook1e 00's Adventure 0kami's Blog 0x41414141 in ?? () 0x7f Blog 0xRick Owned Root ! 0xd00's blog 1 Byte 1A23 Blog 1A23 Studio 1Link.Fun 1stwebdesigner 251 2BAB 的工程博客 2ch中文网 360 CERT 360 Netlab Blog - Network Securi 38号车评中心